124I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of 131I-L19-SIP radioimmunotherapy

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 8, 2009, Pages 1235-1244

  Tijink, Bernard M ^a   Perk, Lars R ^a   Budde, Marianne ^a   Stigter Van Walsum, Marijke ^a   Visser, Gerard W M ^a   Kloet, Reina W ^a   Dinkelborg, Ludger M ^b   Leemans, C René ^a   Neri, Dario ^c   Van Dongen, Guus A M S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BAYER PHARMA AG   (Germany)

^c ETH ZURICH   (Switzerland)

Author keywords

Angiogenesis; Extra domain B of fibronectin; L19 SIP; PET imaging; Radioimmunotherapy

Indexed keywords

CETUXIMAB; GUANOSINE PHOSPHATE; IODINE 124; IODINE 131; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY L 19 SIP I 124; MONOCLONAL ANTIBODY L 19 SIP I 131; RADIOACTIVE IODINE; TELLURIUM; UNCLASSIFIED DRUG; 1,3,4,6 TETRACHLORO 3 ALPHA,6 ALPHA DIPHENYLGLYCOLURIL; 1,3,4,6-TETRACHLORO-3 ALPHA,6 ALPHA-DIPHENYLGLYCOLURIL; ANTIBODY; DIAGNOSTIC AGENT; DRUG DERIVATIVE; HYBRID PROTEIN; SIP(L19) FUSION PROTEIN; UREA;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOSIMETRY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMAGE QUALITY; IMMUNOREACTIVITY; ISOTOPE LABELING; MOLECULAR IMAGING; MOUSE; NONHUMAN; PREDICTION; RADIOIMMUNOTHERAPY; RADIOIODINATION; SQUAMOUS CELL CARCINOMA; TISSUE DISTRIBUTION; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; ULTRASOUND SCANNER; XENOGRAFT; ANIMAL; CANCER STAGING; CHEMISTRY; COMPUTER ASSISTED RADIOTHERAPY; FEASIBILITY STUDY; IMMUNOLOGY; INJECTION; METHODOLOGY; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; ANTIBODIES; CELL LINE, TUMOR; FEASIBILITY STUDIES; HUMANS; INJECTIONS; IODINE RADIOISOTOPES; ISOTOPE LABELING; MICE; NEOPLASM STAGING; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; POSITRON-EMISSION TOMOGRAPHY; RADIOIMMUNOTHERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECOMBINANT FUSION PROTEINS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; UREA;

EID: 70349257537     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1096-y     Document Type: Article

References (35)

1. D Neri R Bicknell 2005 Tumour vascular targeting Nat Rev Cancer 5 436 446 15928674 10.1038/nrc1627 1:CAS:528:DC%2BD2MXks1Gmsrw%3D (Pubitemid 40791486)
2. JN Rybak E Trachsel J Scheuermann D Neri 2007 Ligand-based vascular targeting of disease ChemMedChem 2 22 40 17154429 10.1002/cmdc.200600181 1:CAS:528:DC%2BD2sXjsVWjsLk%3D
3. B Carnemolla E Balza A Siri L Zardi MR Nicotra A Bigotti, et al. 1989 A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors J Cell Biol 108 1139 1148 2646306 10.1083/jcb.108.3. 1139 1:CAS:528:DyaL1MXhslWjtrk%3D (Pubitemid 19083757)
4. P Castellani G Viale A Dorcaratto G Nicolo J Kaczmarek G Querze, et al. 1994 The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis Int J Cancer 59 612 618 7525495 10.1002/ijc.2910590507 1:STN:280:DyaK2M%2FkvVyqug%3D%3D (Pubitemid 24358583)
5. MT Birchler D Milisavlijevic M Pfaltz D Neri B Odermatt S Schmid, et al. 2003 Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors Laryngoscope 113 1231 1237 12838025 10.1097/00005537- 200307000-00023 1:CAS:528:DC%2BD3sXltFKjtb0%3D
6. C Ebbinghaus J Scheuermann D Neri G Elia 2004 Diagnostic and therapeutic applications of recombinant antibodies: targeting the extra-domain B of fibronectin, a marker of tumor angiogenesis Curr Pharm Des 10 1537 1549 15134574 10.2174/1381612043384808 1:CAS:528:DC%2BD2cXjsVyku7w%3D (Pubitemid 38559765)
7. L Zardi B Carnemolla A Siri TE Petersen G Paolella G Sebastio, et al. 1987 Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon EMBO J 6 2337 2342 2822387 1:CAS:528:DyaL1cXmvF2qtw%3D%3D
8. A Pini F Viti A Santucci B Carnemolla L Zardi P Neri, et al. 1998 Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from two-dimensional gel J Biol Chem 273 21769 21776 9705314 10.1074/jbc.273.34.21769 1:CAS:528:DyaK1cXlsFOqsL8%3D (Pubitemid 28405353)
9. L Borsi E Balza M Bestagno P Castellani B Carnemolla A Biro, et al. 2002 Selective targeting of tumor vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin Int J Cancer 102 75 85 12353237 10.1002/ijc.10662 1:CAS:528:DC%2BD38XnvFCru7g%3D
10. D Berndorff S Borkowski S Sieger A Rother M Friebe F Viti, et al. 2005 Radioimmunotherapy of solid tumors by targeting extra domain B fibronectin: identification of the best-suited radioimmunoconjugate Clin Cancer Res 11 7053s 7063s 16203802 10.1158/1078-0432.CCR-1004-0015 1:CAS:528:DC%2BD2MXhtVKiurjE (Pubitemid 41428704)
11. BM Tijink D Neri CR Leemans M Budde LM Dinkelborg M Stigter-van Walsum, et al. 2006 Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature J Nucl Med 47 1127 1135 16818947 1:CAS:528:DC%2BD28XnslSmtrk%3D
12. E El-Emir JLJ Dearling A Huhalov MP Robson G Boxer D Neri, et al. 2007 Characterization and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models Br J Cancer 96 1862 1870 17519905 10.1038/sj.bjc.6603806 1:CAS:528: DC%2BD2sXmtlyqtbs%3D (Pubitemid 46912019)
13. C Schliemann D Neri 2007 Antibody-based targeting of the tumor vasculature Biochim Biophys Acta 1776 175 192 17920773 1:CAS:528: DC%2BD2sXht12hsLzO
14. I Verel GWM Visser GAMS van Dongen 2005 The promise of immuno-PET in radioimmunotherapy J Nucl Med 46 Suppl 1 164S 171S 15653665
15. GAMS Van Dongen GMW Visser MN Lub-de Hooge EG De Vries LR Perk 2007 Immuno-PET: a navigator in monoclonal antibody development and applications Oncologist 12 1379 1389 18165614 10.1634/theoncologist.12-12-1379
16. CA Boswell MW Brechbiel 2007 Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view Nucl Med Biol 34 757 787 17921028 10.1016/j.nucmedbio.2007.04.001 1:CAS:528:DC%2BD2sXhtFeiu77K (Pubitemid 47503817)
17. R Rossin D Berndorff M Friebe LM Dinkelborg MJ Welch 2007 Small-animal PET of tumor angiogenesis using a 76Br-labeled human recombinant antibody fragment to the ED-B domain of fibronectin J Nucl Med 48 1172 1179 17574989 10.2967/jnumed.107.040477 1:CAS:528:DC%2BD2sXhtVertL%2FM (Pubitemid 47052658)
18. SR Rangan 1972 A new human cell line (FaDu) from a hypopharyngeal carcinoma Cancer 29 117 121 4332311 10.1002/1097-0142(197201)29:1<117::AID- CNCR2820290119>3.0.CO;2-R 1:STN:280:DyaE38%2FotVygtQ%3D%3D
19. SM Qaim A Hohn T Bastian KM El-Azoney G Blessing S Spellerberg, et al. 2003 Some optimisation studies relevant to the production of high-purity 124I and 120gI at a small-sized cyclotron Appl Radiat Isot 58 69 78 12485666 10.1016/S0969-8043(02)00226-9 1:CAS:528:DC%2BD38XpsFKkt7Y%3D (Pubitemid 35453949)
20. Monograph 01/2008:2314 sodium iodide (123I) solution for radiolabeling. European Pharmacopoeia. Strasbourg: European Directorate for the Quality of Medicines & HealthCare (EDQM); 2007:1010.
21. I Verel GWM Visser MJWD Vosjan R Finn R Boellaard GAMS van Dongen 2004 High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy Eur J Nucl Med Mol Imaging 31 1645 1652 15290121 10.1007/s00259-004-1632-8 1:CAS:528:DC%2BD2cXhtVCmurrI (Pubitemid 40104611)
22. C Qiu-e H Zhide L Zubi W Jialin X Qiheng 1998 Highly sensitive spectrophotometric determination of trace amounts of tellurium(IV) with the tungstate-basic dyes-poly(vinyl alcohol) system Analyst (Lond) 123 695 697 10.1039/a707722j 1:CAS:528:DyaK1cXhvFOhsL8%3D (Pubitemid 28196133)
23. GWM Visser RP Klok JW Klein-Gebbink T Ter Linde GAMS Van Dongen CF Molthoff 2001 Optimal quality (131)I-monoclonal antibodies upon high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN J Nucl Med 42 509 519 11337531 1:CAS:528:DC%2BD3MXmvFOqtL4%3D
24. HWAM de Jong FHP van Velden RW Kloet FL Buijs R Boellaard AA Lammertsma 2007 Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner Phys Med Biol 52 1505 1526 17301468 10.1088/0031-9155/52/5/019 (Pubitemid 46646401)
25. C Comtat F Bataille C Michel JP Jones M Sibomana L Janeiro, et al. 2004 OSEM-3D reconstruction strategies for the ECAT HRRT IEEE NSS Conf Rec 6 3492 3496
26. W Cai X Chen 2008 Multimodality molecular imaging of tumor angiogenesis J Nucl Med 48 113S 128S 10.2967/jnumed.107.045922 (Pubitemid 351948040)
27. M Santimaria G Moscatelli GL Viale L Giovannoni G Neri F Viti, et al. 2003 Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancer Clin Cancer Res 9 571 579 12576420 1:CAS:528:DC%2BD3sXhtVKksrs%3D
28. D Berndorff S Borkowski D Moosmayer F Viti B Müller-Tiemann S Sieger, et al. 2006 Imaging of tumor angiogenesis using 99mTc-labeled human recombinant anti-ED-B fibronectin antibody fragments J Nucl Med 47 1707 1716 17015908 1:CAS:528:DC%2BD28XhtFKjtrbE
29. A Lövqvist A Sundin H Alström J Carlsson H Lundqvist 1997 Pharmacokinetics and experimental PET imaging of a bromine-67-labeled monoclonal anti-CEA antibody J Nucl Med 38 395 401 9074527
30. J Barbet JF Chatal F Gauche J Martino 2006 Which radionuclides will nuclear medicine need tomorrow? Eur J Nucl Med Mol Imaging 33 627 630 16741760 10.1007/s00259-006-0116-4 (Pubitemid 43846753)
31. R Finn NKV Cheung C Divgi J St Germain M Graham K Pentlow, et al. 1991 Technical challenges associated with the radiolabeling of monoclonal antibodies utilizing short-lived, positron emitting radionuclides Int J Rad Appl Instrum B 18 9 13 2010313 1:STN:280:DyaK3M7osFSktg%3D%3D
32. FT Lee C Hall A Rigopoulos J Zweit K Pathmaraj GJ O'Keefe, et al. 2001 Immuno-PET of human colon xenograft-bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody J Nucl Med 42 764 769 11337573 1:STN:280:DC%2BD3MvkvVGhtw%3D%3D
33. DR Collingridge VA Carroll M Glaser EO Aboagye S Osman OC Hutchinson, et al. 2002 The development of [124I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography Cancer Res 62 5912 5919 12384557 1:CAS:528:DC%2BD38XotFyktLo%3D
34. M Glaser DR Collingridge EO Aboagye L Bouchier-Hayes OC Hutchinson SJ Martin, et al. 2003 Iodine-124 labelled annexin-V as a potential radiotracer to study apoptosis using positron emission tomography Appl Radiat Isot 58 55 62 12485664 10.1016/S0969-8043(02)00239-7 1:CAS:528:DC%2BD38XpsFKkt7g%3D (Pubitemid 35453947)
35. TK Nikula M Bocchia MJ Curcio G Sgouros Y Ma RD Finn, et al. 1995 Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radiodination on IgG immunoreactivity Mol Immunol 32 865 872 7565813 10.1016/0161-5890(95)00052-G 1:CAS:528:DyaK2MXosVSlur4%3D